Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Deoxycholic acid is effective for reducing chin fat but can cause side effects and serious complications, so careful patient evaluation is needed.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Dermoscopy now helps diagnose various skin, hair, and nail issues, improving patient care and treatment understanding.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Higher fiber intake may reduce psoriasis severity, but more research is needed for effective dietary strategies.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Effective treatments for severe alopecia areata are still lacking.

Macrophages help maintain mammary stem cells and tissue balance through specific signaling pathways.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.